HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aaberge, L. Articles by Forfang, K. Search for Related Content PubMed PubMed Citation Articles by Aaberge, L. Articles by Forfang, K.

CLINICAL STUDY: RANSMYOCARDIAL REVASCULARIZATION

Continued symptomatic improvement three to five years after transmyocardial revascularization with co₂ laser

A late clinical follow-up of the norwegian randomized trial with transmyocardial revascularization

Lars Aaberge, MD^*,*, Kjell Rootwelt, MD, PhD, Svein Blomhoff, MD, PhD, Kjell Saatvedt, MD, PhD, Michel Abdelnoor, MPH, PhD^|| and Kolbjorn Forfang, MD, PhD^*

^* Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway
Department of Clinical Chemistry/Section of Nuclear Medicine, Rikshospitalet University Hospital, Oslo, Norway
Department of Psychiatry, Rikshospitalet University Hospital, Oslo, Norway
Feiringklinikken, Feiring, Oslo, Norway
^|| Ullevaal University Hospital, Oslo, Norway

Manuscript received October 15, 2001; revised manuscript received February 21, 2002, accepted February 22, 2002.

^* Reprint requests and correspondence: Dr. Lars Aaberge, Feiringklinikken, N-2093 Feiring, Norway.
laaaberg{at}online.no

OBJECTIVES: The goals of this study were to assess late clinical outcome and left ventricular ejection fraction (LVEF) after transmyocardial revascularization with CO₂ laser (TMR).

BACKGROUND: During the 1990s TMR emerged as a treatment option for patients with refractory angina not eligible for conventional revascularization. Few reports exist on clinical effects and LVEF >3 years after TMR.

METHODS: One hundred patients with refractory angina not eligible for conventional revascularization were block-randomized 1:1 to receive continued medical treatment or medical treatment combined with TMR. The patients were evaluated at baseline and after 3, 12 and 43 (range: 32 to 60) months with end points to angina, hospitalizations due to acute myocardial infarctions or unstable angina, heart failure and LVEF. Mortality was registered and MOS 36 Short-Form Health Survey answered at baseline and after 3, 6 and 12 months.

RESULTS: Forty-three months after TMR, angina symptoms were still significantly improved, and unstable angina hospitalizations reduced by 55% (p < 0.001). Heart failure treatment (p < 0.01) increased, whereas the number of acute myocardial infarctions, LVEF and mortality was not affected. Quality of life was improved 3, 6 and 12 months after TMR.

CONCLUSIONS: Forty-three months after TMR, angina symptoms and hospitalizations due to unstable angina were significantly reduced, heart failure treatment increased and LVEF and mortality were seemingly unaffected.

Abbreviations and Acronyms   DSE   dobutamine stress echocardiography   LVEF   left ventricular ejection fraction   MCS   summary mental component scale   MT   medical treatment   MUGA   multiple-gated acquisition   NYHA   New York Heart Association   OBL   baseline outcome variable   OFU   follow-up outcome variable   PCS   summary physical component scale   QoL   quality of life   SF-36   MOS 36 Short-Form Health Survey   SPECT   technetium 99m-tetrofosmin myocardial perfusion scan   TMR   transmyocardial revascularization with CO2 laser

This article has been cited by other articles:

				K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text]

				S. Banai, S. Ben Muvhar, K. H. Parikh, A. Medina, H. Sievert, A. Seth, J. Tsehori, Y. Paz, A. Sheinfeld, and G. Keren Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study. J. Am. Coll. Cardiol., May 1, 2007; 49(17): 1783 - 1789. [Abstract] [Full Text] [PDF]

				D. McNab, S. N. Khan, L. D. Sharples, J. Y. Ryan, C. Freeman, N. Caine, S. Tait, I. Hardy, and P. M. Schofield An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial Eur. Heart J., May 1, 2006; 27(9): 1048 - 1053. [Abstract] [Full Text] [PDF]

				J. E. Nordrehaug and M. Salem Treatment of chronic refractory angina pectoris--light at the end of the tunnel? Eur. Heart J., May 1, 2006; 27(9): 1007 - 1009. [Full Text] [PDF]

				G. S. Allen Mid-Term Results After Thoracoscopic Transmyocardial Laser Revascularization Ann. Thorac. Surg., August 1, 2005; 80(2): 553 - 558. [Abstract] [Full Text] [PDF]

				K. B. Allen, R. D. Dowling, and W. Richenbacher Reply. Ann. Thorac. Surg., June 1, 2005; 79(6): 2200 - 2201. [Full Text] [PDF]

				A. Sanni and J. Dunning Is transmyocardial revascularisation of benefit to people with 'no option' angina? Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 586 - 592. [Abstract] [Full Text] [PDF]

				S. K. Mouli, J. Fronza, R. Greene, E. S. Robert, and K. A. Horvath What is the Optimal Channel Density for Transmyocardial Laser Revascularization? Ann. Thorac. Surg., October 1, 2004; 78(4): 1326 - 1331. [Abstract] [Full Text] [PDF]

				K. B. Allen, R. D. Dowling, D. R. Schuch, T. A. Pfeffer, S. Marra, E. A. Lefrak, T. L. Fudge, M. Mostovych, S. Szentpetery, S. P. Saha, et al. Adjunctive transmyocardial revascularization: five-year follow-up of a prospective, randomized trial Ann. Thorac. Surg., August 1, 2004; 78(2): 458 - 465. [Abstract] [Full Text] [PDF]

				K. B. Allen, R. D. Dowling, W. W. Angell, D. M. Gangahar, T. L. Fudge, W. Richenbacher, S. L. Selinger, M. R. Petracek, and D. Murphy Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial Ann. Thorac. Surg., April 1, 2004; 77(4): 1228 - 1234. [Abstract] [Full Text] [PDF]

				C. R. Bridges, K. A. Horvath, W. C. Nugent, D. M. Shahian, C. K. Haan, R. J. Shemin, K. B. Allen, and F. H. Edwards The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization Ann. Thorac. Surg., April 1, 2004; 77(4): 1494 - 1502. [Abstract] [Full Text] [PDF]